Pontus Protein receives shareholder approval for the sale of its aquaponics business

Pontus Protein has received the approval of its shareholders at its annual and special meeting of shareholders held in Vancouver on December 23, 2022, for, among other things, the sale of substantially all of the Company's assets, more particularly all of those assets used in its aquaponics farming business.

More than 98% of the shares represented at the meeting voted in favor of the sale of the Aquaponics Segment to CEVAS Technology Inc. ("CEVAS"), pursuant to the asset purchase agreement dated November 3, 2022, between the Company and CEVAS (the "Transaction"). In addition to this, each incumbent director of the Company was re-elected to serve until the close of the next annual meeting.

Subject to the final approval of the TSX Venture Exchange, the Company intends to close the Transaction in January 2023.

In addition, the Company announced that it has appointed Andy Wu as the Chief Financial Officer of the Company to replace Jason Ding. The Company would like to thank Jason Ding for his contribution to the Company.

For more information:
Pontus Proteins


Publication date:

Receive the daily newsletter in your email for free | Click here

Other news in this sector:

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.

Click here for a guide on disabling your adblocker.